Infinity to Participate in Two Upcoming Investor Conferences
Get Alerts INFI Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass., Feb. 17, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that management will be participating at the following investor conferences:
- RBC Capital Markets Global Healthcare Conference, New York, February 24th at 11:30 a.m. ET
- Cowen and Company 36th Annual Health Care Conference, Boston, March 9th at 8:00 a.m. ET
A live webcast of these presentations will be accessible on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. For more information on Infinity, please refer to the company's website at www.infi.com.
Contact: Christi WaarichSenior Manager, Investor Relations617-453-1363 or [email protected]
Logo - http://photos.prnewswire.com/prnh/20150916/267365LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/infinity-to-participate-in-two-upcoming-investor-conferences-300221182.html
SOURCE Infinity Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Company Crash.gg Launches Human-First Workforce Model to Challenge the AI Automation Trend
- Tzuldareno Reviews: Is Tzuldareno Legit? Full Trading Platform Analysis!
- How McArthurGlen’s Travel Advisor Portal Turns Europe’s Designer Outlets Into a Bookable, Trackable Premium Asset for Travel Advisors
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
RBC Capital, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share